Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 1;24(21):15868.
doi: 10.3390/ijms242115868.

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0

Affiliations
Editorial

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0

Carmen Abate et al. Int J Mol Sci. .

Abstract

For some time now, the research on sigma receptors has been at a high level of maturity but, despite everything that has already been achieved, further work in this field still holds huge appeal, with vast possibilities for original discoveries [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Couly S., Goguadze N., Yasui Y., Kimura Y., Wang S.M., Sharikadze N., Wu H.E., Su T.P. Knocking out sigma-1 receptors reveals diverse health problems. Cell Mol. Neurobiol. 2022;42:597–620. doi: 10.1007/s10571-020-00983-3. - DOI - PMC - PubMed
    1. Maurice T. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expert. Opin. Drug Discov. 2021;16:373–389. doi: 10.1080/17460441.2021.1838483. - DOI - PubMed
    1. Kraskovskaya N.A., Bezprozvanny I.B. Normalization of calcium balance in striatal neurons in Huntington’s disease: Sigma 1 receptor as a potential target for therapy. Biochemistry. 2021;86:471–479. doi: 10.1134/S0006297921040076. - DOI - PubMed
    1. Abatematteo F.S., Niso M., Contino M., Leopoldo M., Abate C. Multi-Target Directed Ligands (MTDLs) Binding the σ1 receptor as promising therapeutics: State of the art and perspectives. Int. J. Mol. Sci. 2021;22:6359. doi: 10.3390/ijms22126359. - DOI - PMC - PubMed
    1. Sałaciak K., Pytka K. Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. Neurosci. Biobehav. Rev. 2022;132:1114–1136. doi: 10.1016/j.neubiorev.2021.10.037. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources